CRIS EBITDA | CURIS, INC.

CURIS, INC. (CRIS) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$9.94M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$11.52M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$6.92M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$8.25M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2010-12-31 to 2012-12-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$9.94M	(m)	$0.00	(m)	(m)	-$9.65M*	(m)	(m)	(m)	(m)
2026-03-31	Reported	(m)	-$11.52M	(m)	$0.00	(m)	(m)	-$9.00M	(m)	(m)	(m)	(m)
2025-09-30	Reported	(m)	-$6.92M	(m)	$3.18M	(m)	(m)	-$5.57M*	(m)	(m)	(m)	(m)
2025-06-30	Reported	(m)	-$8.25M	(m)	$2.75M	(m)	(m)	-$8.01M*	(m)	(m)	(m)	(m)
2025-03-31	Reported	(m)	-$10.16M	(m)	$2.38M	(m)	(m)	-$7.25M	(m)	(m)	(m)	(m)
2024-09-30	Reported	(m)	-$10.57M	(m)	$2.93M	(m)	(m)	-$5.94M*	(m)	(m)	(m)	(m)
2024-06-30	Reported	(m)	-$12.51M	(m)	$2.55M	(m)	(m)	-$11.13M*	(m)	(m)	(m)	(m)
2024-03-31	Reported	(m)	-$12.47M	(m)	$2.09M	(m)	(m)	-$13.23M	(m)	(m)	(m)	(m)
2023-09-30	Reported	(m)	-$12.37M	(m)	$2.83M	(m)	$0.00*	-$8.18M*	(m)	(m)	(m)	(m)
2023-06-30	Reported	(m)	-$12.14M	(m)	$2.20M	(m)	$0.00*	-$7.87M*	(m)	(m)	(m)	(m)
2023-03-31	Reported	(m)	-$11.63M	(m)	$2.30M	(m)	$0.00	-$12.20M	(m)	(m)	(m)	(m)
2022-09-30	Reported	(m)	-$12.61M	(m)	$2.83M	(m)	$52.00K*	-$13.12M*	(m)	(m)	(m)	(m)
2022-06-30	Reported	(m)	-$15.06M	(m)	$2.39M	(m)	$353.00K*	-$12.13M*	(m)	(m)	(m)	(m)
2022-03-31	Reported	(m)	-$15.13M	(m)	$2.06M	(m)	$11.00K	-$16.82M	(m)	(m)	(m)	(m)
2021-09-30	Reported	(m)	-$10.05M	(m)	$3.04M	(m)	$0.00*	-$9.61M*	(m)	(m)	(m)	(m)
2021-06-30	Reported	(m)	-$10.65M	(m)	$2.29M	(m)	$0.00*	-$6.66M*	(m)	(m)	(m)	(m)
2021-03-31	Reported	(m)	-$8.80M	(m)	$2.19M	(m)	$0.00	-$13.18M	(m)	(m)	(m)	(m)
2020-12-31	Reported	(m)	-$6.28M	(m)	$3.02M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	(m)	-$4.71M	(m)	$2.74M	(m)	$158.00K*	-$5.88M*	(m)	(m)	(m)	(m)
2020-06-30	Reported	(m)	-$5.43M	(m)	$2.36M	(m)	$258.00K*	-$5.13M*	(m)	(m)	(m)	(m)
2020-03-31	Reported	(m)	-$8.48M	(m)	$2.71M	(m)	$241.00K	-$9.02M	(m)	(m)	(m)	(m)
2019-12-31	Reported	(m)	-$7.33M	(m)	$3.29M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	(m)	-$5.32M	(m)	$2.86M	(m)	$0.00*	-$6.70M*	(m)	(m)	(m)	(m)
2019-06-30	Reported	(m)	-$6.14M	(m)	$2.09M	(m)	$41.00K*	-$6.67M*	(m)	(m)	(m)	(m)
2019-03-31	Reported	(m)	-$5.56M	(m)	$1.77M	(m)	$0.00	-$7.23M	(m)	(m)	(m)	(m)
2018-12-31	Reported	(m)	-$5.15M	(m)	$2.75M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	(m)	-$6.42M	(m)	$2.85M	(m)	$8.00K*	-$8.22M*	(m)	(m)	(m)	(m)
2018-06-30	Reported	(m)	-$7.86M	(m)	$2.36M	(m)	$0.00*	-$6.94M*	(m)	(m)	(m)	(m)
2018-03-31	Reported	(m)	-$9.91M	(m)	$2.47M	(m)	$77.00K	-$9.96M	(m)	(m)	(m)	(m)
2017-12-31	Reported	(m)	-$7.13M	(m)	$3.26M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	(m)	-$14.47M	(m)	$2.44M	(m)	$21.00K*	-$16.48M*	(m)	(m)	(m)	(m)
2017-06-30	Reported	(m)	-$13.11M	(m)	$2.06M	(m)	$74.00K*	(m)	(m)	(m)	(m)	(m)
2017-03-31	Reported	(m)	-$15.05M	(m)	$2.13M	(m)	$52.00K	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	(m)	-$10.76M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	(m)	-$27.79M	(m)	(m)	(m)	$13.00K*	(m)	(m)	(m)	(m)	(m)
2016-06-30	Reported	(m)	-$10.68M	(m)	(m)	(m)	$248.00K*	(m)	(m)	(m)	(m)	(m)
2016-03-31	Reported	(m)	-$8.81M	(m)	(m)	(m)	$8.00K	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	(m)	-$13.25M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	(m)	-$4.84M	(m)	(m)	(m)	$33.00K*	(m)	(m)	(m)	(m)	(m)
2015-06-30	Reported	(m)	-$7.37M	(m)	(m)	(m)	$43.00*	(m)	(m)	$2.00M	(m)	(m)
2015-03-31	Reported	(m)	-$31.02M	(m)	(m)	(m)	$14.96K	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	(m)	-$4.81M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	(m)	-$4.75M	(m)	(m)	(m)	$6.90K*	(m)	(m)	$3.71M	(m)	(m)
2014-06-30	Reported	(m)	-$1.54M	(m)	(m)	(m)	(m)	(m)	(m)	$3.33M	(m)	(m)
2014-03-31	Reported	(m)	-$4.75M	(m)	(m)	(m)	(m)	(m)	(m)	$3.15M	(m)	(m)
2013-12-31	Reported	(m)	-$4.48M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	(m)	$130.37K	(m)	(m)	(m)	$99.50K*	$277.40K*	(m)	$4.17M*	(m)	(m)
2013-09-30	Reported	(m)	$130.37K	(m)	(m)	(m)	(m)	(m)	(m)	$4.17M	(m)	(m)
2013-06-30	Reported	(m)	-$706.20K	(m)	(m)	(m)	$0.00*	$23.84K*	(m)	$3.17M	(m)	(m)
2013-03-31	Reported	(m)	-$4.36M	(m)	(m)	(m)	$34.96K	-$4.33M	(m)	$2.63M	(m)	(m)
2012-09-30	Reported	(m)	-$4.96M	(m)	(m)	(m)	$8.51K*	-$4.18M*	(m)	$3.04M	(m)	(m)
2012-06-30	Reported	(m)	-$2.43M	(m)	(m)	(m)	$23.14K*	-$1.61M*	(m)	$4.50M	(m)	(m)
2012-03-31	Reported	(m)	$2.20M	(m)	(m)	(m)	$10.51K	$3.94M	(m)	$5.24M	(m)	(m)
2011-09-30	Reported	(m)	-$4.82M	(m)	(m)	(m)	$3.12K*	-$4.42M*	(m)	$3.04M	(m)	(m)
2011-06-30	Reported	(m)	-$4.62M	(m)	(m)	(m)	$206.79K*	-$4.20M*	(m)	$3.14M	(m)	(m)
2011-03-31	Reported	(m)	-$5.33M	(m)	(m)	(m)	$39.59K	-$4.63M	(m)	$3.06M	(m)	(m)
2010-09-30	Reported	(m)	-$1.76M	(m)	(m)	(m)	$56.29K*	-$831.02K*	(m)	$3.01M	(m)	(m)
2010-06-30	Reported	(m)	-$3.93M	(m)	(m)	(m)	(m)	(m)	(m)	$2.24M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	-$5.71M	(m)	$9.44M	(m)	(m)	-$27.20M	(m)	(m)	(m)	$0.00
2024-12-31	Reported	(m)	-$44.54M	(m)	$10.91M	(m)	(m)	-$39.56M	(m)	(m)	(m)	$0.00
2023-12-31	Reported	(m)	-$48.33M	(m)	$10.02M	(m)	$0.00	-$38.43M	(m)	(m)	(m)	(m)
2022-12-31	Reported	(m)	-$53.02M	(m)	$10.16M	(m)	$416.00K	-$54.34M	(m)	(m)	(m)	(m)
2021-12-31	Reported	(m)	-$42.06M	(m)	$10.65M	(m)	$0.00	-$37.62M	(m)	(m)	(m)	(m)
2021-09-30	Rolling	(m)	-$35.77M*	(m)	$10.54M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-06-30	Rolling	(m)	-$30.44M*	(m)	$10.24M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-03-31	Rolling	(m)	-$25.22M*	(m)	$10.31M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-12-31	Reported	(m)	-$24.90M	(m)	$10.84M	(m)	$677.00K	-$25.74M	(m)	(m)	(m)	(m)
2020-12-31	Rolling	(m)	-$24.90M*	(m)	$10.84M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Rolling	(m)	-$25.96M*	(m)	$11.10M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$26.57M*	(m)	$11.21M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	-$27.28M*	(m)	$10.95M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	(m)	-$24.36M	(m)	$10.00M	(m)	$41.00K	-$26.20M	(m)	(m)	(m)	(m)
2019-12-31	Rolling	(m)	-$24.36M*	(m)	$10.00M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$22.17M*	(m)	$9.47M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$23.26M*	(m)	$9.46M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	-$24.98M*	(m)	$9.73M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	(m)	-$29.33M	(m)	$10.43M	(m)	$85.00K	-$30.07M	(m)	(m)	(m)	(m)
2018-12-31	Rolling	(m)	-$29.33M*	(m)	$10.43M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	-$31.31M*	(m)	$10.94M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$39.37M*	(m)	$10.53M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$44.62M*	(m)	$10.23M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	(m)	-$49.76M	(m)	$9.90M	(m)	$188.00K	-$48.35M	(m)	(m)	(m)	(m)
2017-12-31	Rolling	(m)	-$49.76M*	(m)	$9.90M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	-$53.40M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$66.71M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$64.28M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	(m)	-$58.04M	(m)	(m)	(m)	$329.00K	-$35.81M	(m)	$18.00M	(m)	(m)
2016-12-31	Rolling	(m)	-$58.04M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	-$60.52M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	-$37.58M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$34.27M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	(m)	-$56.48M	(m)	(m)	(m)	$48.00K	-$29.89M	(m)	(m)	(m)	(m)
2015-12-31	Rolling	(m)	-$56.48M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	-$48.05M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	-$47.96M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	-$42.13M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	(m)	-$15.86M	(m)	(m)	(m)	$92.00K	-$16.81M	(m)	$13.66M	(m)	(m)
2014-12-31	Rolling	(m)	-$15.86M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Rolling	(m)	-$15.53M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	(m)	-$9.42M	(m)	(m)	(m)	$153.01K	-$9.54M	(m)	$12.93M	(m)	(m)
2012-12-31	Reported	-$18.49M	(m)	(m)	(m)	-108.96%	$104.97K	-$15.19M	(m)	$15.49M	(m)	(m)
2011-12-31	Reported	-$7.1M	(m)	(m)	(m)	-48.06%	$260.40K	-$4.56M	(m)	$13.69M	(m)	(m)
2010-12-31	Reported	-$4.95M	(m)	(m)	(m)	-30.95%	$274.84K	-$1.63M	(m)	$11.37M	(m)	(m)
2009-12-31	Reported	(m)	-$10.04M	(m)	(m)	(m)	$19.54K	-$7.59M	(m)	$9.93M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Silexion Therapeutics Corp (SLXN)		$0.001B
Calidi Biotherapeutics, Inc. (CLDI)	United States	$0.003B
VivoSim Labs, INC. (VIVS)	United States	$0.003B
WINDTREE THERAPEUTICS INC /DE/ (WINT)	United States	$0.003B	-0.32
PharmaCyte Biotech, Inc. (PMCB)	United States	$0.005B
AIM ImmunoTech Inc. (AIM)	United States	$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)	United States	$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)	United States	$0.007B
TScan Therapeutics, Inc. (TCRX)	United States	$0.008B	-1.23
Senti Biosciences Holdings, Inc. (SNTI)	United States	$0.011B	-0.70